bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figure 2 from A Molecular Taxonomy for Urothelial Carcinoma
Authors: Sjödahl Gottfrid , Lauss Martin , Lövgren Kristina , Chebil Gunilla , Gudjonsson Sigurdur , Veerla Srinivas , Patschan Oliver , Aine Mattias , Fernö Mårten , Ringnér Markus , Månsson Wiking , Liedberg Fredrik , Lindgren David , Höglund Mattias
Published: April 2023

PDF file - 425K, Clusters of genes with coordinated expression across samples
Supplementary Table from Onartuzumab (MetMAb): Using Nonclinical Pharmacokinetic and Concentration–Effect Data to Support Clinical Development
Authors: Xiang Hong , Bender Brendan C. , Reyes Arthur E. , Merchant Mark , Jumbe Nelson L. ‘Shasha’ , Romero Mally , Davancaze Teresa , Nijem Ihsan , Mai Elaine , Young Judy , Peterson Amy , Damico-Beyer Lisa A.
Published: April 2023

PDF file, 54K, Estimation of percentage of patients to achieve TSC (15 ug/mL) at Ctrough ss with Q3W dose regimen.
Supplementary Figure Legends from Therapeutic Enhancement of ER Stress by Insulin-Like Growth Factor I Sensitizes Myeloma Cells to Proteasomal Inhibitors
Authors: Tagoug Inès , Jordheim Lars Petter , Herveau Stéphanie , Matera Eva-Laure , Huber Anne-Laure , Chettab Kamel , Manié Serge , Dumontet Charles
Published: April 2023

PDF file - 69K
Supplementary Figure Legend from γ-H2AX Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results from 2 Phase I Clinical Trials of SJG-136 (SG2000)
Authors: Wu Jenny , Clingen Peter H. , Spanswick Victoria J. , Mellinas-Gomez Maria , Meyer Tim , Puzanov Igor , Jodrell Duncan , Hochhauser Daniel , Hartley John A.
Published: April 2023

PDF file - 62K
Supplementary Figure 2 from In Vitro and In Vivo Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells
Authors: Chauhan Dharminder , Ray Arghya , Viktorsson Kristina , Spira Jack , Paba-Prada Claudia , Munshi Nikhil , Richardson Paul , Lewensohn Rolf , Anderson Kenneth C.
Published: April 2023

PDF file - 281K, Supplementary Figure 2 MM.1S cells were treated with indicated concentrations of melphalan or mel-flufen for 4h. The cells were harvested and subjected to alkaline comet assay, and the fluorescent images were visualized (excitation/emission:496 nm/522 nm). Comet tails were scored based on their DNA content, which is proportional to the fluorescence intensity of the tail image. The data is presented as percentage of DNA damage (represented in tail region) versus total DNA present in head and tail region (mean � SD; P < 0.05, n=50).
Supplementary Figure 4 from Electrocardiographic Studies of Romidepsin Demonstrate Its Safety and Identify a Potential Role for KATP Channel
Authors: Noonan Anne M. , Eisch Robin A. , Liewehr David J. , Sissung Tristan M. , Venzon David J. , Flagg Thomas P. , Haigney Mark C. , Steinberg Seth M. , Figg William D. , Piekarz Richard L. , Bates Susan E.
Published: April 2023

Supplementary Figure 4 - PDF file 314K, Changes in mean heart rate during cycles 1 when patients taking betablockers were excluded
Supplementary Figure 2 from A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer
Authors: Schoenfeld Jonathan D. , Margalit Danielle N. , Kasperzyk Julie L. , Shui Irene M. , Rider Jennifer R. , Epstein Mara M. , Meisner Allison , Kenfield Stacey A. , Martin Neil E. , Nguyen Paul L. , Kantoff Philip W. , Giovannucci Edward L. , Stampfer Meir J. , Mucci Lorelei A.
Published: April 2023

PDF file - 51K, Time to event stratified by genotype for men who reached the composite outcome. Boxplots show the interquartile range (boxes) and outliers (whiskers).
Supplementary Figure 6 from Nupr1-Aurora Kinase A Pathway Provides Protection against Metabolic Stress-Mediated Autophagic-Associated Cell Death
Authors: Hamidi Tewfik , Cano Carla E. , Grasso Daniel , Garcia Maria Noé , Sandi Maria José , Calvo Ezequiel L. , Dagorn Jean-Charles , Lomberk Gwen , Urrutia Raul , Goruppi Sandro , Carracedo Arkaitz , Velasco Guillermo , Iovanna Juan L.
Published: April 2023

PDF file, 231K, Protective role of Nupr1 and AURKA on MiaPaCa2 cells in control experiment using additional siRNA sequences.
Supplementary Figure 1 from Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation
Authors: Duan Zhenfeng , Zhang Jianming , Choy Edwin , Harmon David , Liu Xianzhe , Nielsen Petur , Mankin Henry , Gray Nathanael S. , Hornicek Francis J.
Published: April 2023

PDF file, 28K, CDK11 cDNA rescue assay.
Supplementary Figure 1 from Nupr1-Aurora Kinase A Pathway Provides Protection against Metabolic Stress-Mediated Autophagic-Associated Cell Death
Authors: Hamidi Tewfik , Cano Carla E. , Grasso Daniel , Garcia Maria Noé , Sandi Maria José , Calvo Ezequiel L. , Dagorn Jean-Charles , Lomberk Gwen , Urrutia Raul , Goruppi Sandro , Carracedo Arkaitz , Velasco Guillermo , Iovanna Juan L.
Published: April 2023

PDF file, 355K, mRNA expression in glucose starvation- and hypoxia-treated pancreatic cancer cells expressing or not Nupr1.
Supplementary Figure 1 from Stromal Responses among Common Carcinomas Correlated with Clinicopathologic Features
Authors: Chen Julia L-Y. , Espinosa Iñigo , Lin Albert Y. , Liao Olivia Y-W. , van de Rijn Matt , West Robert B.
Published: April 2023

PDF file, 911K, The expression profiles of DTF fibroblast core gene signature in five lung cancer datasets, including caArray-beer-00153 (Supp Fig1A), GSE4573 (Supp Fig1B), GSE10245 (Supp Fig1C), GSE10445 (Supp Fig1D) and GSE11969 (Supp Fig1E).
Supplementary Materials and Methods, Figure Legends, Tables 1 - 3 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Authors: Manceau Gilles , Imbeaud Sandrine , Thiébaut Raphaële , Liébaert François , Fontaine Karine , Rousseau Francis , Génin Bérengère , Corre Delphine Le , Didelot Audrey , Vincent Marc , Bachet Jean-Baptiste , Chibaudel Benoist , Bouché Olivier , Landi Bruno , Bibeau Frédéric , Leroy Karen , Penault-Llorca Frédérique , Van Laethem Jean-Luc , Demetter Pieter , Tejpar Sabine , Rossi Simona , Mosakhani Neda , Österlund Pia , Ristamäki Raija , Sarhadi Virinder , Knuutila Sakari , Boige Valérie , André Thierry , Laurent-Puig Pierre
Published: April 2023

PDF file - KB, Supplementary Table S1. Taqman information for expression analysis of microRNAs. Supplementary Table S2. List of the 11 microRNAs used in the classifier model. Supplementary Table S3. List of the genes with a fc<0.77 (Down-regulated) or fc>1.3 (Up-regulated) and a pvalue≤0.05 identified in the expression array.
Supplementary Figure 4 from Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies
Authors: Brauer Matthew J. , Zhuang Guanglei , Schmidt Maike , Yao Jenny , Wu Xiumin , Kaminker Joshua S. , Jurinka Stefanie S. , Kolumam Ganesh , Chung Alicia S. , Jubb Adrian , Modrusan Zora , Ozawa Tomoko , James C. David , Phillips Heidi , Haley Benjamin , Tam Rachel N.W. , Clermont Anne C. , Cheng Jason H. , Yang Sherry X. , Swain Sandra M. , Chen Daniel , Scherer Stefan J. , Koeppen Hartmut , Yeh Ru-Fang , Yue Peng , Stephan Jean-Philippe , Hegde Priti , Ferrara Napoleone , Singh Mallika , Bais Carlos
Published: April 2023

PDF file - 233K, Fig S4A. Validation and application of a compacted 22-gene VDV subset in human clinical samples. Fig S4B and C. Stratification of NO16966 patients by VEGF and CD31 expression levels.
Supplementary Figure 2 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Authors: Manceau Gilles , Imbeaud Sandrine , Thiébaut Raphaële , Liébaert François , Fontaine Karine , Rousseau Francis , Génin Bérengère , Corre Delphine Le , Didelot Audrey , Vincent Marc , Bachet Jean-Baptiste , Chibaudel Benoist , Bouché Olivier , Landi Bruno , Bibeau Frédéric , Leroy Karen , Penault-Llorca Frédérique , Van Laethem Jean-Luc , Demetter Pieter , Tejpar Sabine , Rossi Simona , Mosakhani Neda , Österlund Pia , Ristamäki Raija , Sarhadi Virinder , Knuutila Sakari , Boige Valérie , André Thierry , Laurent-Puig Pierre
Published: April 2023

PDF file - 64KB, Kaplan-Meier PFS according to level of expression of hsa-miR-31-3p in training set 1.
Supplementary Figure 1 from Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies
Authors: Brauer Matthew J. , Zhuang Guanglei , Schmidt Maike , Yao Jenny , Wu Xiumin , Kaminker Joshua S. , Jurinka Stefanie S. , Kolumam Ganesh , Chung Alicia S. , Jubb Adrian , Modrusan Zora , Ozawa Tomoko , James C. David , Phillips Heidi , Haley Benjamin , Tam Rachel N.W. , Clermont Anne C. , Cheng Jason H. , Yang Sherry X. , Swain Sandra M. , Chen Daniel , Scherer Stefan J. , Koeppen Hartmut , Yeh Ru-Fang , Yue Peng , Stephan Jean-Philippe , Hegde Priti , Ferrara Napoleone , Singh Mallika , Bais Carlos
Published: April 2023

PDF file - 113K, Fig S1. Kinetics of anti-VEGF effects on proliferation (ki67) and tumor burden in the RIP-TβAg model.
Supplementary Methods from Relationships between LDH-A, Lactate, and Metastases in 4T1 Breast Tumors
Authors: Rizwan Asif , Serganova Inna , Khanin Raya , Karabeber Hazem , Ni Xiaohui , Thakur Sunitha , Zakian Kristen L. , Blasberg Ronald , Koutcher Jason A.
Published: April 2023

Supplementary Methods - PDF file 158K, Supplemental methods contain both techniques and further data strengthening the manuscript. These include our Analysis of Breast Cancer Microarray Datasets, Generation of LDH-A knockdown and control cell lines and In vitro assays, and in vivo methods (MR measurements)
Supplementary Figure 6 from Temozolomide Does Not Impair Gene Therapy-Mediated Antitumor Immunity in Syngeneic Brain Tumor Models
Authors: Candolfi Marianela , Yagiz Kader , Wibowo Mia , Ahlzadeh Gabrielle E. , Puntel Mariana , Ghiasi Homayon , Kamran Neha , Paran Christopher , Lowenstein Pedro R. , Castro Maria G.
Published: April 2023

PDF file - 1495K, Effect of TMZ on the number of T cells in spleen and bone marrow.
Supplementary Table 2 from Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer
Authors: Davies Kurtis D. , Le Anh T. , Theodoro Mariana F. , Skokan Margaret C. , Aisner Dara L. , Berge Eamon M. , Terracciano Luigi M. , Cappuzzo Federico , Incarbone Matteo , Roncalli Massimo , Alloisio Marco , Santoro Armando , Camidge D. Ross , Varella-Garcia Marileila , Doebele Robert C.
Published: April 2023

PDF file - 66K, Clinical and histopathologic features of patients included in TMA
Supplementary Figure 4 from Temozolomide Does Not Impair Gene Therapy-Mediated Antitumor Immunity in Syngeneic Brain Tumor Models
Authors: Candolfi Marianela , Yagiz Kader , Wibowo Mia , Ahlzadeh Gabrielle E. , Puntel Mariana , Ghiasi Homayon , Kamran Neha , Paran Christopher , Lowenstein Pedro R. , Castro Maria G.
Published: April 2023

PDF file - 220K, Correlation between survival and circulating levels of HMGB1.
Supplementary Figures 1 - 3 from Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection
Authors: Collinson Fiona , Hutchinson Michelle , Craven Rachel A. , Cairns David A. , Zougman Alexandre , Wind Tobias C. , Gahir Narinder , Messenger Michael P. , Jackson Sharon , Thompson Douglas , Adusei Cybil , Ledermann Jonathan A. , Hall Geoffrey , Jayson Gordon C. , Selby Peter J. , Banks Rosamonde E.
Published: April 2023

PDF file - 269K, Supplementary Figure 1: Differences in AGP, mesothelin and FLT4 concentrations between responders and non responders in the discovery sample set (n=10); Supplementary Figure 2: Progression-free survival in validation cohort I; Supplementary Figure 3: Baseline concentrations of mesothelin, FLT4, AGP and CA125 in: a). validation cohort I, b). validation cohort II, and c). both validation cohorts combined.
Supplementary Figure Legend from Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1
Authors: Wang Rui , Liu Changda , Xia Lijuan , Zhao Guisen , Gabrilove Janice , Waxman Samuel , Jing Yongkui
Published: April 2023

PDF file - 112K
Supplementary Figure 7 from Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1
Authors: Wang Rui , Liu Changda , Xia Lijuan , Zhao Guisen , Gabrilove Janice , Waxman Samuel , Jing Yongkui
Published: April 2023

PDF file - 187K, Apoptosis detection by FACS in several AML cell lines
Supplementary Table 1 from The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma
Authors: Tang Liang , Tan Ye-Xiong , Jiang Bei-Ge , Pan Yu-Fei , Li Shuang-Xi , Yang Guang-Zhen , Wang Min , Wang Qing , Zhang Jian , Zhou Wei-Ping , Dong Li-Wei , Wang Hong-Yang
Published: April 2023

PDF file - 128K, Relationship between Gli1, Gli2 protein expression and clinicopathologic characteristics in the validation cohort.
Supplementary Methods from The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma
Authors: Tang Liang , Tan Ye-Xiong , Jiang Bei-Ge , Pan Yu-Fei , Li Shuang-Xi , Yang Guang-Zhen , Wang Min , Wang Qing , Zhang Jian , Zhou Wei-Ping , Dong Li-Wei , Wang Hong-Yang
Published: April 2023

PDF file - 157K
Supplementary Tables 3 - 6 from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer
Authors: Patani Neill , Dunbier Anita K. , Anderson Helen , Ghazoui Zara , Ribas Ricardo , Anderson Elizabeth , Gao Qiong , A'hern Roger , Mackay Alan , Lindemann Justin , Wellings Robert , Walker Jill , Kuter Irene , Martin Lesley-Ann , Dowsett Mitch
Published: April 2023

PDF file - 134KB, S3: Top 30 genes significantly affected by E-deprivation: (a) In vitro and (b) FAIMoS (two weeks), (i) Up-regulated and (ii) Down-regulated. Probes are annotated with gene symbols where available; S4: Top 30 genes significantly affected by fulvestrant: (a) In vitro and (b) NEWEST (high-dose), (i) Up-regulated and (ii) Down-regulated. Probes are annotated with gene symbols where available; S5: Top 30 GO functional gene sets significantly affected by E-deprivation: (a) In vitro and (b) FAIMoS (two weeks), (i) Up-regulated and (ii) Down-regulated; S6: Top 30 GO functional gene sets significantly affected by fulvestrant: (a) In vitro and (b) NEWEST (high-dose), (i) Up-regulated and (ii) Down-regulated.
Supplementary Figure 2 from The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma
Authors: Tang Liang , Tan Ye-Xiong , Jiang Bei-Ge , Pan Yu-Fei , Li Shuang-Xi , Yang Guang-Zhen , Wang Min , Wang Qing , Zhang Jian , Zhou Wei-Ping , Dong Li-Wei , Wang Hong-Yang
Published: April 2023

PDF file - 191K, Hedgehog signaling genes expression and copy number change in intrahepatic cholangiocellular carcinoma specimens.
Supplementary Tables 11 - 13 from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer
Authors: Patani Neill , Dunbier Anita K. , Anderson Helen , Ghazoui Zara , Ribas Ricardo , Anderson Elizabeth , Gao Qiong , A'hern Roger , Mackay Alan , Lindemann Justin , Wellings Robert , Walker Jill , Kuter Irene , Martin Lesley-Ann , Dowsett Mitch
Published: April 2023

PDF file - 58KB, S11: Summary of Spearman correlations between up-regulated (n=13) and down-regulated (n=28) genes which were fulvestrant-related (n=41), AURKA and ESR1, in pre-treatment in samples from (a) NEWEST and (b) FAIMoS; S12: Summary of treatment-related genes for which pre-treatment expression correlates significantly with treatment-induced changes in expression of the proliferation-associated gene AURKA: (a) High pre-treatment expression correlates with good response, (b) Low pre-treatment expression correlates with good response, and (c) high pre-treatment expression correlates with good response to low-dose fulvestrant. E-deprivation (ED), fulvestrant (F). Probes are annotated with gene symbols where available; S13: Impact of sixteen weeks of anastrozole on transcripts found to be specifically affected by fulvestrant: (a) Up-regulated and (b) Down-regulated.
Supplementary Table Legends from Clonal Evolution, Genomic Drivers, and Effects of Therapy in Chronic Lymphocytic Leukemia
Authors: Ouillette Peter , Saiya-Cork Kamlai , Seymour Erlene , Li Cheng , Shedden Kerby , Malek Sami N.
Published: April 2023

PDF File - 37K, Legends for Supplementary Tables.
Supplementary Figures 1 - 3 from Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer
Authors: Patani Neill , Dunbier Anita K. , Anderson Helen , Ghazoui Zara , Ribas Ricardo , Anderson Elizabeth , Gao Qiong , A'hern Roger , Mackay Alan , Lindemann Justin , Wellings Robert , Walker Jill , Kuter Irene , Martin Lesley-Ann , Dowsett Mitch
Published: April 2023

PDF file - 556KB, Supplementary Figure 1a: Overview of pre-surgical studies: Fulvestrant (NEWEST), detailing study design (i) and samples (ii). S1b: Anastrozole (FAIMoS), detailing study design (i) and samples (ii). S1c: Summary of patient demographics and tumour characteristics for NEWEST and FAIMoS; Supplementary Figure 2ai: Spearman correlations between fulvestrant (F) and E-deprivation (ED) related and specific genes, selected proliferation-associated and E-regulated index genes in pre-treatment samples from NEWEST (n=22). Direct correlations are indicated in red and inverse correlations in green, with their strength reflected by colour intensity. S2aii: Spearman correlations between fulvestrant (F) and E-deprivation (ED) related and specific genes, selected proliferation-associated and E-regulated index genes in pre-treatment samples from FAIMoS (n=81). Direct correlations are indicated in red and inverse correlations in green, with their strength reflected by colour intensity. Supplementary Figure 2b: Summary of Spearman correlations between up-regulated (n=13) and down-regulated (n=28) genes which were fulvestrant-related (n=41), AURKA and ESR1, in pre-treatment in samples from (i) NEWEST and (ii) FAIMoS. Supplementary Figure 3a/b: mpact of ESR1 knockdown with an siRNA SMARTpool and four constituent oligonucleotides (a), on the mRNA expression of genes differentially down-regulated by fulvestrant (b). S3c: Impact of ESR1 knockdown with an siRNA SMARTpool and four constituent oligonucleotides (a), on the mRNA expression of genes differentially up-regulated by fulvestrant (c).
Supplementary Table 2 from Clonal Evolution, Genomic Drivers, and Effects of Therapy in Chronic Lymphocytic Leukemia
Authors: Ouillette Peter , Saiya-Cork Kamlai , Seymour Erlene , Li Cheng , Shedden Kerby , Malek Sami N.
Published: April 2023

PDF File - 84K, Characteristics of 103 CLL patients not analyzed in longitudinal genomic analysis.
Supplementary Figure Legend from Highly Specific Targeting of the TMPRSS2/ERG Fusion Gene Using Liposomal Nanovectors
Authors: Shao Longjiang , Tekedereli Ibrahim , Wang Jianghua , Yuca Erkan , Tsang Susan , Sood Anil , Lopez-Berestein Gabriel , Ozpolat Bulent , Ittmann Michael
Published: April 2023

PDF file - 51K
Supplementary Figure 1 from Highly Specific Targeting of the TMPRSS2/ERG Fusion Gene Using Liposomal Nanovectors
Authors: Shao Longjiang , Tekedereli Ibrahim , Wang Jianghua , Yuca Erkan , Tsang Susan , Sood Anil , Lopez-Berestein Gabriel , Ozpolat Bulent , Ittmann Michael
Published: April 2023

PDF file - 13351K, Representative images of Ki67 and CD31 immunohistochemistry and TUNEL from VCaP xenograft tumors treated with scrambled control SiRNA or targeted SiRNAs (Si8 or Si14). Immunohistochemistry was developed using DAB, so stained cells are brown, and counterstained with hematoxylin. TUNEL was developed with NBT/BCIP, so apoptotic cells are blue, and counterstained with nuclear fast red. Original magnification: 200X
Supplementary Figure 6 from Antibody-Mediated Delivery of Anti–KRAS-siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer
Authors: Bäumer Sebastian , Bäumer Nicole , Appel Neele , Terheyden Lisa , Fremerey Julia , Schelhaas Sonja , Wardelmann Eva , Buchholz Frank , Berdel Wolfgang E. , Müller-Tidow Carsten
Published: April 2023

Supplementary Figure 6. Proliferation of HCT116 xenografted tumors upon mAB-siRNA treatment.
Supplementary Figure 5 from Antibody-Mediated Delivery of Anti–KRAS-siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer
Authors: Bäumer Sebastian , Bäumer Nicole , Appel Neele , Terheyden Lisa , Fremerey Julia , Schelhaas Sonja , Wardelmann Eva , Buchholz Frank , Berdel Wolfgang E. , Müller-Tidow Carsten
Published: April 2023

Supplementary Figure 5. In vivo toxicity estimation by mouse body weight development.
Supplementary Figure 4 from Antibody-Mediated Delivery of Anti–KRAS-siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer
Authors: Bäumer Sebastian , Bäumer Nicole , Appel Neele , Terheyden Lisa , Fremerey Julia , Schelhaas Sonja , Wardelmann Eva , Buchholz Frank , Berdel Wolfgang E. , Müller-Tidow Carsten
Published: April 2023

Supplementary Figure 4. Clonogenic growth of MDA and A549 cells.
Supplementary Figure 1 from Antibody-Mediated Delivery of Anti–KRAS-siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer
Authors: Bäumer Sebastian , Bäumer Nicole , Appel Neele , Terheyden Lisa , Fremerey Julia , Schelhaas Sonja , Wardelmann Eva , Buchholz Frank , Berdel Wolfgang E. , Müller-Tidow Carsten
Published: April 2023

Supplementary Figure 1. Anti-EGFR antibody-protamine shuttles Alexa Fluor 488-labeled siRNA into EGFR-expressing cells.
Supplementary Materials and Methods from FOXM1c Promotes Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis via Upregulation of Expression of the Urokinase Plasminogen Activator System
Authors: Huang Chen , Xie Dacheng , Cui Jiujie , Li Qi , Gao Yong , Xie Keping
Published: April 2023

Supplementary Materials and Methods: 1. Cell scratch-wound assay. 2. Cell migration assay. 3. Cell invasion assay. 4. Animals. 5. Experimental liver metastases. 6. Western blot analysis.
Supplementary Figure 1 from FOXM1c Promotes Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis via Upregulation of Expression of the Urokinase Plasminogen Activator System
Authors: Huang Chen , Xie Dacheng , Cui Jiujie , Li Qi , Gao Yong , Xie Keping
Published: April 2023

Supplementary Figure S1. Influence of altered expression of FOXM1 isoforms on pancreatic tumor cell migration and invasion.
Supplementary data: Figures S2-S8 from Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia—Implications for Immunotherapy
Authors: Weber Gerrit , Caruana Ignazio , Rouce Rayne H. , Barrett A. John , Gerdemann Ulrike , Leen Ann M. , Rabin Karen R. , Bollard Catherine M.
Published: April 2023

Supplementary data: Figures S2-S8 - PDF file 312K, Supplementary Figure S2: Co-culture experiments of TAA-specific T cells with autologous blasts (Patient ID # 963) Supplementary Figure S3: Co-culture experiments of TAA-specific T cells with autologous blasts (Patient ID # 996) Supplementary Figure S4: Co-culture experiments of TAA-specific T cells with autologous blasts (Patient ID # 1024) Supplementary Figure S5: Co-culture experiments of TAA-specific T cells with autologous blasts (Patient ID # 1025)Supplementary Figure S6: Co-culture experiments of TAA-specific T cells with autologous blasts (Patient ID # 1292) Supplementary Figure S7: Co-culture experiments of TAA-specific T cells with autologous blasts (Patient ID # 1331) Supplementary Figure S8: Co-culture experiments of TAA-specific T cells with autologous blasts (Patient ID # 1339)
Supplementary Table 3 from EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors
Authors: Bladt Friedhelm , Faden Bettina , Friese-Hamim Manja , Knuehl Christine , Wilm Claudia , Fittschen Claus , Grädler Ulrich , Meyring Michael , Dorsch Dieter , Jaehrling Frank , Pehl Ulrich , Stieber Frank , Schadt Oliver , Blaukat Andree
Published: April 2023

PDF file - 77K, In vivo tumor growth inhibition by EMD 1214063 and EMD 1204831. The effect of EMD 1214063 and EMD 1204831 on tumor growth (T/C) was evaluated in in vivo xenograft models, using a panel of human tumor cell lines. Both inhibitors were highly active on tumor models with different types of aberrant c-Met upregulation, that (i) harbor MET gene amplification, (ii) express high levels of c-Met, or (iii) exhibit an HGF/c-Met autocrine loop, while inactive in models without signs of active c-Met signaling.
Supplementary Table 4 from Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy
Authors: Saura Cristina , Bendell Johanna , Jerusalem Guy , Su Shaun , Ru Qinhua , De Buck Stefan , Mills David , Ruquet Sophie , Bosch Ana , Urruticoechea Ander , Beck Joseph T. , Di Tomaso Emmanuelle , Sternberg David W. , Massacesi Cristian , Hirawat Samit , Dirix Luc , Baselga Jose
Published: April 2023

PDF file - 45K, Summary of adverse events suspected to be study-drug related by grade (safety set).
Supplementary Table 2 from Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy
Authors: Saura Cristina , Bendell Johanna , Jerusalem Guy , Su Shaun , Ru Qinhua , De Buck Stefan , Mills David , Ruquet Sophie , Bosch Ana , Urruticoechea Ander , Beck Joseph T. , Di Tomaso Emmanuelle , Sternberg David W. , Massacesi Cristian , Hirawat Samit , Dirix Luc , Baselga Jose
Published: April 2023

PDF file - 38K, Patient disposition (full analysis set).
Supplementary Table 1 from Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy
Authors: Saura Cristina , Bendell Johanna , Jerusalem Guy , Su Shaun , Ru Qinhua , De Buck Stefan , Mills David , Ruquet Sophie , Bosch Ana , Urruticoechea Ander , Beck Joseph T. , Di Tomaso Emmanuelle , Sternberg David W. , Massacesi Cristian , Hirawat Samit , Dirix Luc , Baselga Jose
Published: April 2023

PDF file - 65K, Criteria for defining dose-limiting toxicities.
Supplementary Figures from Estrogen Receptor α Regulates ATM Expression through miRNAs in Breast Cancer
Authors: Guo Xiaojing , Yang Chunying , Qian Xiaolong , Lei Ting , Li Yaqing , Shen Haifa , Fu Li , Xu Bo
Published: April 2023

Supplementary Figures - PDF file 911K, Supplementary Figures
Supplementary Figure 5 from SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Authors: Hassanein Mohamed , Hoeksema Megan D. , Shiota Masakazu , Qian Jun , Harris Bradford K. , Chen Heidi , Clark Jonathan E. , Alborn William E. , Eisenberg Rosana , Massion Pierre P.
Published: April 2023

PDF file - 15K, Silencing SLC1A5 in SCC cells by siRNA attenuates cell growth and reduces glutamine uptake
Supplementary Information from ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer
Authors: Kabbout Mohamed , Garcia Melinda M. , Fujimoto Junya , Liu Diane D. , Woods Denise , Chow Chi-Wan , Mendoza Gabriela , Momin Amin A. , James Brian P. , Solis Luisa , Behrens Carmen , Lee J. Jack , Wistuba Ignacio I. , Kadara Humam
Published: April 2023

Supplementary Information - PDF file 109K, Legends for Supplementary Figures 1-11
Supplementary Figure 3 from SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Authors: Hassanein Mohamed , Hoeksema Megan D. , Shiota Masakazu , Qian Jun , Harris Bradford K. , Chen Heidi , Clark Jonathan E. , Alborn William E. , Eisenberg Rosana , Massion Pierre P.
Published: April 2023

PDF file - 28K, SLC1A5 mediates response to Gln-dependent growth
Supplementary Figure 2 from SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Authors: Hassanein Mohamed , Hoeksema Megan D. , Shiota Masakazu , Qian Jun , Harris Bradford K. , Chen Heidi , Clark Jonathan E. , Alborn William E. , Eisenberg Rosana , Massion Pierre P.
Published: April 2023

PDF file - 39K, Expression of SLC1A5 in lung cancer cell lines
Supplementary Figure 1 from SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Authors: Hassanein Mohamed , Hoeksema Megan D. , Shiota Masakazu , Qian Jun , Harris Bradford K. , Chen Heidi , Clark Jonathan E. , Alborn William E. , Eisenberg Rosana , Massion Pierre P.
Published: April 2023

PDF file - 16K, SLC1A5 protein is overexpressed in NSCLC tissues
Supplementary Data from Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
Authors: Oxnard Geoffrey R. , Paweletz Cloud P. , Kuang Yanan , Mach Stacy L. , O'Connell Allison , Messineo Melissa M. , Luke Jason J. , Butaney Mohit , Kirschmeier Paul , Jackman David M. , Jänne Pasi A.
Published: April 2023

XLSX file - 25K, cfDNA results for figures 2, 4, 5, calculated both as concentration per mL plasma and as percent mutant.
Supplementary Figure 3 from EASL- and mRECIST-Evaluated Responses to Combination Therapy of Sorafenib with Transarterial Chemoembolization Predict Survival in Patients with Hepatocellular Carcinoma
Authors: Liu Lei , Wang Weijuan , Chen Hui , Zhao Yan , Bai Wei , Yin Zhanxin , He Chuangye , Jia Jia , Yang Man , Xia Jielai , Fan Daiming , Han Guohong
Published: April 2023

PDF file - 1413K, Supplementary Fig. 3: Among the subgroup of patients with CR (n=18) based on the enhancement criteria, survival was compared between the patients with a PR (n=7) and SD (n=11) after re-classification based on RECIST. Abbreviations: CR, complete response; PR, partial response; SD, stable disease; RECIST, response evaluation criteria in solid tumors.
Supplementary Table 1 from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
Authors: Adams Sylvia , Kozhaya Lina , Martiniuk Frank , Meng Tze-Chiang , Chiriboga Luis , Liebes Leonard , Hochman Tsivia , Shuman Nicholas , Axelrod Deborah , Speyer James , Novik Yelena , Tiersten Amy , Goldberg Judith D. , Formenti Silvia C. , Bhardwaj Nina , Unutmaz Derya , Demaria Sandra
Published: April 2023

XLS file, 17K, Patient demographics, tumor characteristics, treatment, occurrence and severity of local and systemic adverse events and anti-tumor response per patient (n=10).
Supplementary Table 1 from Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells
Authors: Weide Benjamin , Martens Alexander , Zelba Henning , Stutz Christina , Derhovanessian Evelyna , Di Giacomo Anna Maria , Maio Michele , Sucker Antje , Schilling Bastian , Schadendorf Dirk , Büttner Petra , Garbe Claus , Pawelec Graham
Published: April 2023

PDF file - 58K, Patient characteristics and analysis of overall survival in cohort 2 (39 patients).
Supplementary Table 1 and 2 from Bim Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia
Authors: Gagné Vincent , Rousseau Julie , Labuda Malgorzata , Sharif-Askari Bahram , Brukner Ivan , Laverdière Caroline , Ceppi Francesco , Sallan Stephen E. , Silverman Lewis B. , Neuberg Donna , Kutok Jeffery L. , Sinnett Daniel , Krajinovic Maja
Published: April 2023

Supplementary Table 1 and 2 - PDF file 68K, Supplementary Table 1. Identity of tagSNPs, details of PCR and ASO hybridization Supplementary Table 2. Identity of polymorphisms genotyped only in controls
Supplementary Table 3 from CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
Authors: Nielsen Julie S. , Sahota Rob A. , Milne Katy , Kost Sara E. , Nesslinger Nancy J. , Watson Peter H. , Nelson Brad H.
Published: April 2023

PDF file, 54KB, CA125 levels and NY-ESO-1 autoantibody titres before (Pre) and after (Post) primary surgery and chemotherapy for the 6 HGSC patients shown in Figure 4C. Titres represent mean values from three independent experiments.
Supplementary Table 1 from CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
Authors: Nielsen Julie S. , Sahota Rob A. , Milne Katy , Kost Sara E. , Nesslinger Nancy J. , Watson Peter H. , Nelson Brad H.
Published: April 2023

PDF file, 74KB, Clinical characteristics of patient cohort A.
Supplementary Figure 2 from GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer
Authors: Nebiker Christian A. , Han Junyi , Eppenberger-Castori Serenella , Iezzi Giandomenica , Hirt Christian , Amicarella Francesca , Cremonesi Eleonora , Huber Xaver , Padovan Elisabetta , Angrisani Basilio , Droeser Raoul A. , Rosso Raffaele , Bolli Martin , Oertli Daniel , von Holzen Urs , Adamina Michel , Muraro Manuele G. , Mengus Chantal , Zajac Paul , Sconocchia Giuseppe , Zuber Markus , Tornillo Luigi , Terracciano Luigi , Spagnoli Giulio C.
Published: April 2023

PDF - 480K, CX3CL1/fractalkine gene and protein expression in healthy colon mucosa, CRC and established cell lines.
Supplementary Figures 1 - 15 from Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with BRCA1 and BRCA2 Mutations
Authors: George Joshy , Alsop Kathryn , Etemadmoghadam Dariush , Hondow Heather , Mikeska Thomas , Dobrovic Alexander , deFazio Anna , Smyth Gordon K. , Levine Douglas A. , Mitchell Gillian , Bowtell David D.
Published: April 2023

PDF file - 1609K
Supplementary Tables from PI3K Pathway Dependencies in Endometrioid Endometrial Cancer Cell Lines
Authors: Weigelt Britta , Warne Patricia H. , Lambros Maryou B. , Reis-Filho Jorge S. , Downward Julian
Published: April 2023

Supplementary Tables - PDF file 26K, Supplementary Table 1. Endometrial cancer cell lines and growth media used in this study; Supplementary Table 2. Primers used for PCR amplification from cDNA and sequencing; Supplementary Table 3. Small molecule inhibitors used in this study
Supplementary Table 1 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
Authors: Duru Nadire , Fan Ming , Candas Demet , Menaa Cheikh , Liu Hsin-Chen , Nantajit Danupon , Wen Yunfei , Xiao Kai , Eldridge Angela , Chromy Brett A. , Li Shiyong , Spitz Douglas R. , Lam Kit S. , Wicha Max S. , Li Jian Jian
Published: April 2023

PDF file - 80K, Proteins identified by HPLC-MS/MS analysis are categorized into functional groups
Supplementary Figure 5 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
Authors: Duru Nadire , Fan Ming , Candas Demet , Menaa Cheikh , Liu Hsin-Chen , Nantajit Danupon , Wen Yunfei , Xiao Kai , Eldridge Angela , Chromy Brett A. , Li Shiyong , Spitz Douglas R. , Lam Kit S. , Wicha Max S. , Li Jian Jian
Published: April 2023

PDF file - 513K, IHS of co-activation of HER2/CD44 cells in tumor tissues
Supplementary Material Table S6. from Ligand-Dependent Activation of EGFR in Follicular Dendritic Cells Sarcoma is Sustained by Local Production of Cognate Ligands
Authors: Vermi William , Giurisato Emanuele , Lonardi Silvia , Balzarini Piera , Rossi Elisa , Medicina Daniela , Bosisio Daniela , Sozzani Silvano , Pellegrini Wilma , Doglioni Claudio , Marchetti Antonio , Rossi Giulio , Pileri Stefano , Facchetti Fabio
Published: April 2023

Expression of EGFR by FDC FRC on human lymph nodes.
Supplementary Tables 1 - 4 from Inactivation of the CDKN2A Tumor-Suppressor Gene by Deletion or Methylation Is Common at Diagnosis in Follicular Lymphoma and Associated with Poor Clinical Outcome
Authors: Alhejaily Abdulmohsen , Day Andrew G. , Feilotter Harriet E. , Baetz Tara , LeBrun David P.
Published: April 2023

PDF file - 96K, Table S1: Sequences of primers used in SNP determination by Sequenom iPLEX assay. Table S2: Primers used for deletion analysis by end-point PCR. Table S3: Validation of MethylLight assay for quantification of CpG island methylation at CDKN2A. Table S4: Association between visual scores for p16 and pRb.
Supplementary Figure S5 from Ligand-Dependent Activation of EGFR in Follicular Dendritic Cells Sarcoma is Sustained by Local Production of Cognate Ligands
Authors: Vermi William , Giurisato Emanuele , Lonardi Silvia , Balzarini Piera , Rossi Elisa , Medicina Daniela , Bosisio Daniela , Sozzani Silvano , Pellegrini Wilma , Doglioni Claudio , Marchetti Antonio , Rossi Giulio , Pileri Stefano , Facchetti Fabio
Published: April 2023

Validation of anti-pEGFR antibodies.
Supplementary Figure 2 from Inactivation of the CDKN2A Tumor-Suppressor Gene by Deletion or Methylation Is Common at Diagnosis in Follicular Lymphoma and Associated with Poor Clinical Outcome
Authors: Alhejaily Abdulmohsen , Day Andrew G. , Feilotter Harriet E. , Baetz Tara , LeBrun David P.
Published: April 2023

PDF file - 62K, (A) Overall survival according to CDKN2A deletion status. (B) Overall survival according to CDKN2A methylation status.
Supplementary Methods from Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug
Authors: Shah Vatsal , Taratula Oleh , Garbuzenko Olga B. , Taratula Olena R. , Rodriguez-Rodriguez Lorna , Minko Tamara
Published: April 2023

PDF file - 105K, The supplementary data file contains detailed descriptions of the following methods: MALDI TOF Mass Spectroscopy; Atomic Force Microscopy; Particle Size and Charge; Stability of the Complexes in Serum; Cellular Internalization; Cell Invasion Assay; In Vitro Cytotoxicity; In Vivo Body Distribution with references.
Supplementary Tables 1 - 2 from Smoking and Risk of Low- and High-Grade Prostate Cancer: Results from the REDUCE Study
Authors: Ho Tammy , Howard Lauren E. , Vidal Adriana C. , Gerber Leah , Moreira Daniel , McKeever Madeleine , Andriole Gerald , Castro-Santamaria Ramiro , Freedland Stephen J.
Published: April 2023

Supplementary Table 1: Differences in Baseline Characteristics by Number of On-Study Biopsies Received Among Men with No Cancer on the First On-Study Biopsy. Supplementary Table 2: Association between smoking and prostate cancer risk or disease grade vs. non-smokers from all on-study biopsies.
Supplementary table S2 from Japonicone A Suppresses Growth of Burkitt Lymphoma Cells through Its Effect on NF-κB
Authors: Li Xiaoguang , Yang Xinying , Liu Yanling , Gong Nuoxi , Yao Wenbo , Chen Peizhan , Qin Jiangjiang , Jin Huizi , Li Jingquan , Chu Ruiai , Shan Lei , Zhang Ruiwen , Zhang Weidong , Wang Hui
Published: April 2023

The primary antibody used in this study.
Supplementary Figure Legend from PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
Authors: Chen Benjamin J. , Chapuy Bjoern , Ouyang Jing , Sun Heather H. , Roemer Margaretha G.M. , Xu Mina L. , Yu Hongbo , Fletcher Christopher D.M. , Freeman Gordon J. , Shipp Margaret A. , Rodig Scott J.
Published: April 2023

PDF file - 48K
Supplementary Table S2 from NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases
Authors: Fogliatto Gianpaolo , Gianellini Laura , Brasca Maria G. , Casale Elena , Ballinari Dario , Ciomei Marina , Degrassi Anna , De Ponti Anna , Germani Massimiliano , Guanci Marco , Paolucci Mauro , Polucci Paolo , Russo Micaela , Sola Francesco , Valsasina Barbara , Visco Carlo , Zuccotto Fabio , Donati Daniele , Felder Eduard , Pesenti Enrico , Galvani Arturo , Mantegani Sergio , Isacchi Antonella
Published: April 2023

Supplementary Table S2 - PDF file 66K, Detailed informations of in vivo experiments
Table S6 from MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls
Authors: Li Ang , Yu Jun , Kim Haeryoung , Wolfgang Christopher L. , Canto Marcia Irene , Hruban Ralph H. , Goggins Michael
Published: April 2023

Table S6 - XLSX file 17K, Supplemental Table S6. Diagnostic performance of microRNAs measured by Taqman real-time PCR assays
Supplementary Figure S4 from NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases
Authors: Fogliatto Gianpaolo , Gianellini Laura , Brasca Maria G. , Casale Elena , Ballinari Dario , Ciomei Marina , Degrassi Anna , De Ponti Anna , Germani Massimiliano , Guanci Marco , Paolucci Mauro , Polucci Paolo , Russo Micaela , Sola Francesco , Valsasina Barbara , Visco Carlo , Zuccotto Fabio , Donati Daniele , Felder Eduard , Pesenti Enrico , Galvani Arturo , Mantegani Sergio , Isacchi Antonella
Published: April 2023

Supplementary Figure S4 - PDF file 56K, Antiproliferative activity of NMS-E973 in a panel of BAF3 cells dependent on wild-type and mutated ALK
Table S5 from MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls
Authors: Li Ang , Yu Jun , Kim Haeryoung , Wolfgang Christopher L. , Canto Marcia Irene , Hruban Ralph H. , Goggins Michael
Published: April 2023

Table S5 - XLSX file 31K, Supplemental Table S5. MicroRNAs elevated in serum of patients with pancreatic cancer relative to combined controls by microarray analysis
Table S4 from MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls
Authors: Li Ang , Yu Jun , Kim Haeryoung , Wolfgang Christopher L. , Canto Marcia Irene , Hruban Ralph H. , Goggins Michael
Published: April 2023

Table S4 - XLSX file 18K, Supplemental Table S4. MicroRNAs elevated in serum of patients with pancreatic cancer relative to normal controls by microarray analysis
Supplementary Methods and Table 1 from Role of Hedgehog Signaling in Malignant Pleural Mesothelioma
Authors: Shi Yandong , Moura Ubiratan , Opitz Isabelle , Soltermann Alex , Rehrauer Hubert , Thies Svenja , Weder Walter , Stahel Rolf A. , Felley-Bosco Emanuela
Published: April 2023

PDF file, 36K, Table S1: Primers used for RT-PCR.
Supplementary Data from Predicting Outcome by Images?
Authors: De Ruysscher Dirk
Published: April 2023

Supplementary Data from Predicting Outcome by Images?
Supplementary Figure 2 from Role of Hedgehog Signaling in Malignant Pleural Mesothelioma
Authors: Shi Yandong , Moura Ubiratan , Opitz Isabelle , Soltermann Alex , Rehrauer Hubert , Thies Svenja , Weder Walter , Stahel Rolf A. , Felley-Bosco Emanuela
Published: April 2023

PDF file, 60K, MPM primary cultures maintained without serum in 3% oxygen show a three-fold increase in expression of ABCG2, GLI1 and PATCH1 compared to cultures without serum in 20% oxygen.
Table S1 from Isocitrate Dehydrogenase 1 Is a Novel Plasma Biomarker for the Diagnosis of Non–Small Cell Lung Cancer
Authors: Sun Nan , Chen Zhaoli , Tan Fengwei , Zhang Baihua , Yao Ran , Zhou Chengcheng , Li Jiagen , Gao Yibo , Liu Ziyuan , Tan Xiaogang , Zhou Fang , He Max Y.F , Shao Kang , Li Ning , Qiu Bin , Sun Jian , Yu Yue , Wang Suya , Zhao Yuda , Shi Xuejiao , He Jie
Published: April 2023

The equations used in the models, which were obtained by binary logistic regression.
Figure S1 from Isocitrate Dehydrogenase 1 Is a Novel Plasma Biomarker for the Diagnosis of Non–Small Cell Lung Cancer
Authors: Sun Nan , Chen Zhaoli , Tan Fengwei , Zhang Baihua , Yao Ran , Zhou Chengcheng , Li Jiagen , Gao Yibo , Liu Ziyuan , Tan Xiaogang , Zhou Fang , He Max Y.F , Shao Kang , Li Ning , Qiu Bin , Sun Jian , Yu Yue , Wang Suya , Zhao Yuda , Shi Xuejiao , He Jie
Published: April 2023

Figure S1. IDH1 concentrations in patients with different T stages. (A) IDH1 concentrations in ADC patients with stages T1a-T2a versus stages T2b-T4. (B) IDH1 concentrations in SCC patients with stages T1a-T2a versus stages T2b-T4.
Supplementary Figure 1 from Phase I Study of Pazopanib in Patients with Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
Authors: Shibata Stephen I. , Chung Vincent , Synold Timothy W. , Longmate Jeffrey A. , Suttle A. Benjamin , Ottesen Lone H. , Lenz Heinz-Josef , Kummar Shivaani , Harvey R. Donald , Hamilton Anne L. , O'Neil Bert H. , Sarantopoulos John , LoRusso Patricia , Rudek Michelle A. , Dowlati Afshin , Mulkerin Daniel L. , Belani Chandra P. , Gandhi Leena , Lau S. Cecilia , Ivy S. Percy , Newman Edward M.
Published: April 2023

PDF - 36K, Structure of pazopanib and metabolites.
Supplementary Video 1 from PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction
Authors: Abiko Kaoru , Mandai Masaki , Hamanishi Junzo , Yoshioka Yumiko , Matsumura Noriomi , Baba Tsukasa , Yamaguchi Ken , Murakami Ryusuke , Yamamoto Ayaka , Kharma Budiman , Kosaka Kenzo , Konishi Ikuo
Published: April 2023

AVI file - 3180K, Video S1 is a time-lapse video showing GFP-positive CTLs attacking ID8-control obtained by time-lapse fluorescence microscopy. Methods of the cell preparation are described in the Materials and Methods section. Total time; 136 minutes, the frame rate; 2 minutes, display rate; 10 frames/second. Fig. 4G is related to this video.
Supplementary Figure S2. Blood cell counts from Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)
Authors: Slingluff Craig L. , Petroni Gina R. , Molhoek Kerrington R. , Brautigan David L. , Chianese-Bullock Kimberly A. , Shada Amber L. , Smolkin Mark E. , Olson Walter C. , Gaucher Alison , Chase Cheryl Murphy , Grosh William W. , Weiss Geoffrey R. , Wagenseller Aubrey G. , Olszanski Anthony J. , Martin Lainie , Shea Sofia M. , Erdag Gulsun , Ram Prahlad , Gershenwald Jeffrey E. , Weber Michael J.
Published: April 2023

Blood cell counts for all patients on study, except lymphocytes.
Supplementary Table 3 from A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients
Authors: Tang Hao , Xiao Guanghua , Behrens Carmen , Schiller Joan , Allen Jeffrey , Chow Chi-Wan , Suraokar Milind , Corvalan Alejandro , Mao Jianhua , White Michael A. , Wistuba Ignacio I. , Minna John D. , Xie Yang
Published: April 2023

PDF file - 108K, Comparison with the gene signatures with other signatures.
Supplementary Figure 3 from Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)
Authors: Slingluff Craig L. , Petroni Gina R. , Molhoek Kerrington R. , Brautigan David L. , Chianese-Bullock Kimberly A. , Shada Amber L. , Smolkin Mark E. , Olson Walter C. , Gaucher Alison , Chase Cheryl Murphy , Grosh William W. , Weiss Geoffrey R. , Wagenseller Aubrey G. , Olszanski Anthony J. , Martin Lainie , Shea Sofia M. , Erdag Gulsun , Ram Prahlad , Gershenwald Jeffrey E. , Weber Michael J.
Published: April 2023

PDF file - 126K, Detailed data are shown for selected proteins assayed by RPPA.
Supplementary Figure 2 from Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)
Authors: Slingluff Craig L. , Petroni Gina R. , Molhoek Kerrington R. , Brautigan David L. , Chianese-Bullock Kimberly A. , Shada Amber L. , Smolkin Mark E. , Olson Walter C. , Gaucher Alison , Chase Cheryl Murphy , Grosh William W. , Weiss Geoffrey R. , Wagenseller Aubrey G. , Olszanski Anthony J. , Martin Lainie , Shea Sofia M. , Erdag Gulsun , Ram Prahlad , Gershenwald Jeffrey E. , Weber Michael J.
Published: April 2023

PDF file - 208K, Blood cell counts for all patients on study, except lymphocytes.